Guided bone regeneration with and without rhBMP-2: 17-year results of a randomized controlled clinical trial
Open Access
- 8 January 2022
- journal article
- research article
- Published by Wiley in Clinical Oral Implants Research
- Vol. 33 (3) , 302-312
Abstract
Objectives To assess long-term outcomes of implants placed in conjunction with guided bone regeneration (GBR) with or without recombinant human bone morphogenetic protein-2 (rhBMP-2). Materials and Methods 11 patients with at least two lateral bone defects (split-mouth design) received a total of 34 implants. The defects were treated with a xenogenic bone substitute with (test) or without (control) rhBMP-2 and covered with a collagen membrane. Eight patients could be reexamined after at least 17 years. Wilcoxon signed-rank tests were performed to assess differences between test and control groups. Results The implant survival rate was 100% for all test and control sites. Mean marginal bone levels were 2.51 mm (SD ±1.64) (mesial test), 1.83 mm (SD ±0.93) (mesial control) (p= 0.055), 2.36 (SD ±1.70) (distal test) and 2.13 mm (SD ±0.84) (distal control) (p= 1.000). Compared to the mean values at baseline a mean bone loss of 1.16 mm (SD ±1.60) (test) and 0.70 mm (SD ±1.02) (control) were found. The mean buccal bone gain after 17 years was 5.38 mm (test) and 3.14 mm (control) based on the comparison between the measurements at the cone beam CT after 17 years and the data from the intraoperative measurements at baseline. Further, mean values for (i) bone thickness ranged from 1.36-3.09 mm (test) and 1.18-3.39 mm (control) and for (ii) mucosal thickness of 1.24 mm (test) and 1.26 mm (control). Conclusion Implants placed in conjunction with GBR applying a xenogenic bone substitute and a collagen membrane with and without the addition of rhBMP-2 demonstrate excellent clinical and radiographic results after at least 17 years.Keywords
This publication has 48 references indexed in Scilit:
- Combined Osteotome‐Induced Ridge Expansion and Guided Bone Regeneration Simultaneous with Implant Placement: A Biometric StudyClinical Implant Dentistry and Related Research, 2013
- In vitro assessment of artifacts induced by titanium dental implants in cone beam computed tomographyClinical Oral Implants Research, 2012
- Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow‐up of 5 yearsClinical Oral Implants Research, 2012
- Long‐term outcome of implants placed with guided bone regeneration (GBR) using resorbable and non‐resorbable membranes after 12–14 yearsClinical Oral Implants Research, 2012
- A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learnedThe Spine Journal, 2011
- Clinical and radiographic comparison of implants in regenerated or native bone: 5‐year resultsClinical Oral Implants Research, 2009
- Bone morphogenetic protein‐2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphateClinical Oral Implants Research, 2007
- Autogenous onlay bone grafts vs. alveolar distraction osteogenesis for the correction of vertically deficient edentulous ridges: a 2–4‐year prospective study on humansClinical Oral Implants Research, 2007
- Randomized Study Evaluating Recombinant Human Bone Morphogenetic Protein‐2 for Extraction Socket AugmentationJournal of Periodontology, 2005
- The Plaque Control RecordJournal of Periodontology, 1972